SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $5,000 | -44.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $9,000 | -43.8% | 10,000 | -50.0% | 0.00% | 0.0% |
| Q3 2015 | $16,000 | -46.7% | 20,000 | +100.0% | 0.00% | -66.7% |
| Q2 2015 | $30,000 | +20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $25,000 | -3.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $26,000 | -63.4% | 10,000 | 0.0% | 0.00% | -62.5% |
| Q3 2014 | $71,000 | +9.2% | 10,000 | 0.0% | 0.01% | +33.3% |
| Q2 2014 | $65,000 | -99.9% | 10,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $66,100,000 | +39.5% | 10,000 | 0.0% | 0.01% | +40.0% |
| Q4 2013 | $47,400,000 | -4.4% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q3 2013 | $49,600,000 | +95284.6% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $52,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |